Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) (ICD-10 G93.3) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06005246

Munich ME/CFS Cohort Study

The Munich cohort study MUC-CFS aims at the characterization and long-term follow-up of myalgic encephalitis/chronic fatigue syndrome (ME/CFS) in young people a…

Germany200 participantsStarted 2019-01-22

All recent trials (3 shown)

Not Yet RecruitingNot Applicable

NCT07317401

Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo…

This study is testing a new treatment for people with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and long-term symptoms after COVID-19. Both co…

Denmark104 participantsStarted 2026-06-01

Treatment: Intermittent hypoxia-hyperoxia treatment (IHHT), Placebo

Active — Not RecruitingNot Applicable

NCT06731179

A Prospective Study to Evaluate the Role of T-Cell Dysfunction in Patients Who Present Symptoms Associated With Long COV…

This is a longitudinal observational study recruiting individuals that have attended three clinical sites with symptoms associated with a diagnosis of long COVI…

United Kingdom160 participantsStarted 2024-12-10